weight loss injection retatrutide Promises Big Loss, but Safety Remains a Question 🎙️ NEW EPISODE: Retatrutide—The Triple

This may include optimizing heart failure management, treating respiratory infections, adjusting asthma or COPD medications, or addressing sleep apnea with continuous positive airway pressure (CPAP) therapy

Whether these effects are ultimately relevant to the long-term impact of such agents on the progression of kidney disease also seen in diabetes and obesity is not yet known

Tirzepatide offers cardiovascular protection (38% reduction in heart failure events), liver fat reduction and MASH resolution (44-62% of patients), sleep apnea improvement (up to 63% AHI reduction), blood pressure reduction (up to 5.8 mmHg), cholesterol improvement (24.9% triglyceride reduction), kidney protection (33% fewer major kidney events), joint pain reduction, PCOS symptom improvement, and systemic inflammation reduction

Mochi reports average first-year loss of 36 lbs and 4+ million cumulative pounds across patients

Its legally allowed only during FDA-declared shortages of the brand-name drug

Latent TGFbeta complexes are transglutaminase cross-linked to fibrillin to facilitate TGFbeta activation